Incorrect eTable 9 in Supplement 1
Clinical Scorecard: Erroneous eTable 9 in Supplement 1 Corrected
At a Glance
| Category | Detail |
|---|
| Condition | Hyperkalemia |
| Key Mechanisms | SGLT2 inhibitors and RAAS inhibitors interaction |
| Target Population | Individuals receiving RAAS inhibitors |
| Care Setting | Clinical research |
Key Highlights
- Correction of eTable 9 in Supplement 1
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals receiving RAAS inhibitors
Clinical Best Practices
Related Resources & Content
